Cyber incident surveillance · analysis completed 2026-10-20 18:49:10 UTC
Boston Scientific
CIK 0000885725 · status watch · overall tier elevated. Within 9.3% of S&P's stated leverage level of 2.5x on the as-reported proxy (S&P adjustments not applied) basis; Business risk scores 4 of 5 (elevated); Liquidity risk scores 5 of 5 (severe).
Business risk
Financial risk
Engine tier: low · engine tier low
Key factors
- post-event band index 2 (30% to 45%) vs pre-event 2: 0 band(s) weaker Corporate Methodology Table 17
- relative distance 0.1536 to boundary 30 >= 0.1 Corporate Methodology para 118
- post-event band index 2 (2x to 3x) vs pre-event 2: 0 band(s) weaker Corporate Methodology Table 17
Liquidity gate
Engine tier: high · engine tier high
Key factors
- gate state fail: post-event A/B 1.17x vs 1.2x fail / 1.32x pass; stressed A-B 1,671,944,315 scoring_rules.md 4.3
Governance evidence
Engine tier: not scored · no evidence flags
Key factors
- no governance evidence flags identified in the reviewed filings scoring_rules.md 4.5
S&P stated conditions
S&P's own published conditions, excerpts verified on the live public page. Distances name their basis.
| Side | Condition | Stated level | Engine value | Distance | Source |
|---|---|---|---|---|---|
| unfavorable | leverage (sustained)"We could lower our rating on Boston Scientific if the company sustains its leverage above 2.5x." | 2.5x | 2.27x | 9.3% | 2025-02-19 |
Distances compare as-reported proxies with S&P's adjusted levels unless the basis says otherwise; for CoreWeave and Applied Digital the proxy understates leverage (S&P adjustments for leases and guarantees are not applied). Open analyst inputs: contracted_asset_sales, expected_shareholder_distributions, working_capital_change_12m.